Breakthrough cancer genome analysis in time and space: novel oncotargets and early drug development

Pharmacogenomics. 2018 Nov;19(17):1303-1310. doi: 10.2217/pgs-2018-0141. Epub 2018 Oct 23.

Authors

Ioannis D Kyrochristos^{1

2}, Demosthenes E Ziogas^{1

3}, Persefoni Antoniou^{1

2}, Michail Mitsis², Efstathios G Lykoudis⁴, Dimitrios H Roukos^{1

2

5}

Affiliations

¹ Centre for Biosystems & Genome Network Medicine, Ioannina University, Ioannina, Greece.
² Department of Surgery, University Hospital of Ioannina, Ioannina, Greece.
³ Department of Surgery, 'G Hatzikosta' General Hospital, Ioannina, Greece.
⁴ Department of Plastic Surgery, University Hospital of Ioannina, Ioannina, Greece.
⁵ Department of Systems Biology, Biomedical Research Foundation of the Academy of Athens (BRFAA), Athens, Greece.

PMID: 30348059
DOI: 10.2217/pgs-2018-0141

No abstract available

Keywords: drug development; genome sequencing; oncotargets.

MeSH terms

Drug Development / methods
Genome / genetics*
Humans
Neoplasms / genetics*
Precision Medicine / methods